Detalhe da pesquisa
1.
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Age Ageing
; 51(5)2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595256
2.
Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study.
Clin Microbiol Infect
; 30(4): 515-521, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984511
3.
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
iScience
; 26(4): 106457, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999095
4.
Small form factor flow virometer for SARS-CoV-2.
Biomed Opt Express
; 13(3): 1609-1619, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415002
5.
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
Life Sci Alliance
; 5(12)2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961779
6.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Viruses
; 13(6)2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204754
7.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Sci Rep
; 11(1): 2608, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33510275
8.
ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression.
Clin Infect Dis
; 50(7): 1022-32, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20192730
9.
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.
PLoS One
; 13(3): e0193773, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29558468
10.
Rate and predictors of progression in elite and viremic HIV-1 controllers.
AIDS
; 30(8): 1209-20, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26854807
11.
Identification of a cluster of HIV-1 controllers infected with low replicating viruses.
PLoS One
; 8(10): e77663, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204910
12.
Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
J Acquir Immune Defic Syndr
; 64(3): 225-31, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23714744
13.
Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
Immunobiology
; 217(9): 889-94, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22333575
14.
Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.
PLoS One
; 7(2): e31928, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22384103
15.
Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individuals.
AIDS
; 26(4): 527-8, 2012 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22317832
16.
Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease.
J Infect Dis
; 196(6): 895-9, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17703421
17.
Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.
Antimicrob Agents Chemother
; 49(5): 1907-14, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15855513